Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2021 Q1- Text added to 2021 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
ablation, academic, adductor, Argentina, back, batch, Brazil, canal, capture, charge, CI, clarity, closure, Coda, Colombia, confidence, contrasted, creation, curve, Delta, discharge, eligible, Eurofarma, eventual, excellence, flexion, fossa, fourth, gave, genicular, hospital, housed, IGOR, Incentive, intake, interval, Latin, length, listing, LOS, low, Mexico, milligram, moderate, motion, Multivesicular, neurological, NRS, optimizing, Orange, organization, patent, perioperative, popliteal, preoperative, radiofrequency, ratably, ratio, refundable, relevant, replacing, Restated, rib, safeguarded, sciatic, show, showed, spasticity, straight, superficial, surgeon, tall, thousand, underwent, upfront, usage, USPTO, variant, Verve
Removed:
create, DepoCyt, DepoCyte, incur, institutional, persist, realize, traded, validated
Valuein 2021 Q1 filing- Value in 2021 Q2 filing
Original filings
Filing view